Skip to content

Validation IMU and EMG Algorithms in Stroke Patients

Validation IMU and EMG Algorithms in Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05205824
Enrollment
7
Registered
2022-01-25
Start date
2021-12-22
Completion date
2022-05-25
Last updated
2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

The objective is to validate the algorithms for movement analysis that were developed previously in healthy participants, in a small study with stroke patients. Stroke subjects will be measured while performing tasks like walking, sitting and standing while wearing light-weight inertial measurements units (IMUs) incorporating 3D accelerometers, 3D gyroscopes and surface electromyography. During the measurements subjects will be recorded on video that serves as ground truth when validating the implemented algorithms for movement analysis. A face blurring program will be used for all video footage.

Detailed description

Subjects will perform the following tasks: 30 sec stationary sitting/standing/lying; 10m walk test; L-test; 8-figure walking test; daily life task; stepping over small obstacles; walk in the corridor. During the measurments IMU will be placed at: sternum; sacrum; bilateral wrists; bilateral shanks; bilateral upper legs; both feet. Surface EMG of bilateral rectus femoris; vastus lateralis; medial gastrocnemius and soleus will be measured.

Interventions

OTHERalgorithm validation

stroke subjects are measured to validate algorithms previously developed after including healthy subjects

Sponsors

Roessingh Research and Development
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* min 18 yrs of age; history of previous stroke; unilateral affected;able to walk without supervision (FAC-score min 4);able to perform activities of daily living without assistance (self-reported); written informed consent.

Exclusion criteria

* subjects with neurological or motor disorders that could interfere with the measurements (other than stroke) or severe deficits in communication, memory and understanding.

Design outcomes

Primary

MeasureTime frameDescription
Inertial measurement unit data1-2 hoursActivity data of the sensors attached to various body parts

Secondary

MeasureTime frameDescription
surface EMG-data1-2 hoursrectus femoris/vastus lateralis/gastrocnemius/soleus data

Other

MeasureTime frameDescription
Heightat inclusionHeight (in cm)
Leg lengthat inclusionLeg length (in cm)
Time since strokeat inclusiontime since stroke (in years)
anonymized video data1-2 hoursVideo data of the measurements performed
Body sideat inclusionAffected and dominant body side (left or right)
FAC-scoreat inclusionFunctional Ambulation Categories score (0-5 points) to assess independence of walking
Motricity Indexat inclusionMotricity index lower limb (0-33 points)
Type of strokeat inclusiontype of stroke (ischemic or hemorrhagic)
Ageat inclusionAge (in years)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026